Bonus BioGroup Ltd.
BBIXF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $3,330 | $3,330 | $3,171 | $4,230 |
| G&A Expenses | $2,801 | $2,801 | -$5,865 | $2,515 |
| SG&A Expenses | $2,801 | $2,801 | -$5,865 | $2,515 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $8,342 | $0 |
| Operating Expenses | $6,131 | $6,131 | $5,648 | $6,745 |
| Operating Income | -$6,131 | -$6,131 | -$5,648 | -$6,745 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$204 | -$204 | -$212 | -$243 |
| Pre-Tax Income | -$6,334 | -$6,334 | -$5,860 | -$6,988 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$6,334 | -$6,334 | -$5,860 | -$6,988 |
| % Margin | – | – | – | – |
| EPS | -0.009 | -0.009 | -0.008 | -0.006 |
| % Growth | 0% | -13.8% | -33.3% | – |
| EPS Diluted | -0.009 | -0.009 | -0.008 | -0.006 |
| Weighted Avg Shares Out | 698,800 | 698,800 | 698,800 | 1,167,929 |
| Weighted Avg Shares Out Dil | 698,800 | 698,800 | 698,800 | 1,167,925 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | -$302 | $54 |
| Interest Expense | $204 | $204 | $174 | $297 |
| Depreciation & Amortization | $689 | $689 | $702 | $698 |
| EBITDA | -$5,442 | -$5,442 | -$4,984 | -$5,993 |
| % Margin | – | – | – | – |